abstract |
The present invention relates to a method for the treatment of a neuropsychiatric disease (eg bipolar disorder) by the administration of a prostaglandin or a prostaglandin derivative (eg latanoprost) to a subject (eg a human) and Relates to the composition. [Selection figure] None |